Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)—A Bicenter Retrospective Study on Diagnosis, Course, and Therapy

Keyphrases

• Acquired Angioedema Due to C1-inhibitor Deficiency 100%
• Hereditary Angioedema 50%
• C1 Inhibitor 30%
• Late-onset 20%
• Severely Affected 20%
• Malignancy 20%
• Diagnostic Delay 20%
• Symptom Onset 20%
• On Demand 10%
• Age of Onset 10%
• Germany 10%
• Autoimmune Disease 10%
• Clinical Data 10%
• Therapeutic Management 10%
• Southern Germany 10%
• Retrospective Analysis 10%
• Icatibant 10%
• Off-label Use 10%
• Biological Data 10%
• Angioedema 10%
• Lymphatics 10%
• Condition Management 10%
• Deficiency Symptoms 10%
• Indications for Treatment 10%
• C1-INH Concentrate 10%
• Papillary Thyroid Carcinoma 10%
• Symptom Control 10%
• Long-term Prophylaxis 10%
• C1 Inhibitor Deficiency 10%
• Acquired Angioedema 10%
• Hematological Diseases 10%
• Symptomatic Patients 10%
• Symptom Diagnosis 10%
• Solid Neoplasm 10%

Medicine and Dentistry

• Retrospective Study 100%
• Angioedema 100%
• Complement Component C1s Inhibitor 100%
• Hereditary Angioedema 41%
• Isoniazid 33%
• Cancer 16%
• Diagnostic Delay 16%
• Lymph Duct 8%
• Therapeutic Management 8%
• Autoimmune Disease 8%
• Papillary Thyroid Cancer 8%
• Icatibant 8%

Immunology and Microbiology

• C1-Inhibitor 100%
• Hereditary Angioedema 41%
• Face 16%
• Autoimmune Disease 8%
• Thyroid 8%
• Data Processing 8%